Victrex PLC
12 February 2002
12 February 2002
Victrex plc
AGM Statement
At the Annual General Meeting of Victrex plc to be held today, Chairman Peter
Warry will make the following statement:
'As noted in our preliminary statement, sales for the first quarter were
impacted by global economic conditions. However, we have seen demand increase
in the second quarter and current demand levels would translate to volume for
the year of around 1,200 tonnes with second half sales volume being greater than
the first half.
As well as seeing early signs of stronger core demand, we are commercialising
new applications at a similar rate to last year. We have also continued to grow
our development pipeline beyond the record level reached at the end of last
year.
We are achieving better than expected gross margin improvement, principally as a
result of further operational efficiencies and a strong performance from
Invibio, our medical implant materials business.
Despite the current challenges caused by the world economy, we can see clear
indications of demand recovering and are confident in the Group's prospects.'
The Company's interim trading update for the six months to 30 March 2002 will be
issued on Tuesday 9 April 2002.
- End -
Enquiries
Victrex plc
David Hummel, Chief Executive 0207 357 9477 (12 February 2002)
Michael Peacock, Finance Director 01253 897700 (thereafter)
Hogarth Partnership Limited
Nick Denton / Tom Leatherbarrow 0207 357 9477
Victrex plc is an innovative, world-leading, high performance materials group.
It has manufacturing plants and research facilities in the UK, and sales and
distribution centres serving over 30 countries world-wide. It is the sole
manufacturer of PEEKa polymer.
PEEKa polymer is a high performance thermoplastic with a unique combination of
properties, which include exceptional chemical, wear, electrical and temperature
resistance, as well as dimensional stability and numerous processing
capabilities. These properties enable engineers to produce cost-effective
designs for critical applications in such diverse markets as the industrial,
automotive, electronics, aerospace, medical and food sectors.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.